Juniper Pharmaceuticals Inc is a specialty pharmaceutical company. The Company is engaged in developing therapeutics that addresses unmet medical needs in women\'s health. Its pipeline product includes COL-1077, a lidocaine bioadhesive gel.
| Website: | www.juniperpharma.com |
| Main Phone: | +1 617 639-1500 |
| Address: | 33 Arch Street |
| State: | MA |
| City / Town: | Boston |
| Country: | USA |
| Postal Code: | 02110 |
| Exchange: | NGS |
| Employees: | 105 |
| NAICS: | Pharmaceutical P |
| Last Price 4.63 | Change $ 0.075 | Change % 1.65 | Tick N/A |
| Bid 4.30 | Bid Size 100.00 | Ask 4.65 | Ask Size 800.00 |
| Open 4.60 | High 4.65 | Low 4.45 | Prev Close 4.55 |
| Last Trade | Volume 24,030 | 52 Wk Hi 6.40 | 52 Wk Low 3.65 |
| Market Cap 50.2 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 10,844,113.00 | EPS (TTM) 0.75 | PE Ratio 6.10 | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 6 | 17 |
| Number of Buys | 6 | 17 |
| Number of Sells | 0 | 0 |
| Net Activity | 40933 | 74448 |
| Last 10 Buys | Shares |
|---|---|
| Ann C. Merrifield | 1,000 |
| Nikin Patel | 1,000 |
| Frank C. Condella | 1,000 |
| Nikin Patel | 1,000 |
| James A. Geraghty | 1,000 |
| Nikin Patel | 1,000 |
| James A. Geraghty | 1,000 |
| Frank C. Condella | 1,000 |
| Donald H. Hunter | 1,000 |
| Frank C. Condella | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| N/A | 0 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 20 | 20 | 20 | 16.5 |
| Low Target Price Estimate | 15 | 15 | 15 | 6.7 |
| Mean Target Price Estimate | 16.67 | 16.67 | 16.67 | 9.98 |
| Standard Deviation | 2.89 | 2.89 | 2.89 | 5.64 |
| Date of Most Recent Estimate | 08/08/16 | 08/08/16 | 07/20/16 | 08/19/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 8-K | Report of unscheduled material events or corporate changes. | 7 | 2016-08-18 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 37 | 2016-08-04 |
| 8-K | Report of unscheduled material events or corporate changes. | 11 | 2016-08-04 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-03 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-03 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-03 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-03 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-03 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-03 |
| 3 | Initial statement of beneficial ownership of securities | 1 | 2016-08-01 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 1 | 3 | 3 | 3 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 2 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 2.33 | 1 | 1 | 1 |
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
